Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles. Founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016, Evox Therapeutics is backed by investors that include Innovate UK, Oxford Sciences Innovation, GV, OrbiMed, and Eli Lilly and is headquartered in Oxford.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Health Care, Pharmaceutical
FOUNDERS:
Matthew Wood, Per Lundin, Samir EL Andaloussi
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
